Chiu Fu-Chun, Chang Sheng-Nan, Lin Jou-Wei, Hwang Juey-Jen, Chen Yih-Sharng
National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan.
J Thorac Cardiovasc Surg. 2009 Dec;138(6):1326-30. doi: 10.1016/j.jtcvs.2009.03.038. Epub 2009 Jun 10.
The objective of this study was to find the best treatment strategy in patients who had acute coronary syndrome and ST-segment elevation myocardial infarction sustaining cardiogenic shock.
Patients having cardiogenic shock owing to acute coronary syndrome and ST-segment elevation myocardial infarction who required hemodynamic support with intra-aortic balloon counterpulsation were retrospectively retrieved from the clinical information system in a tertiary medical center in Taiwan. A propensity score-based matching process was applied to find equalized groups with documented involvement of more than 2 coronary vessels who received percutaneous coronary intervention only (PCI only group) and who underwent subsequent coronary artery bypass graft surgery after percutaneous coronary intervention (PCI+CABG group). A logistic regression model was used to find the factors associated with 30-day mortality.
The propensity analysis identified 44 patients in the PCI only group (35 men, 65 +/- 2 years, and 9 women, 75 +/- 4 years) and the other 44 patients in the PCI+CABG group (31 men, 67 +/- 2 years, and 13 women, 71 +/- 2 years) who had comparable baseline characteristics. The 30-day mortality, 40.9% in the PCI only group and 20.5% in the PCI+CABG group, was positively associated with percutaneous coronary intervention only (odds ratio, 3.33; 95% confidence intervals, 1.14-10.0; P = .03), increased age (odds ratio, 1.06 for each year; 95% confidence intervals, 1.01-1.12; P = .01) and a need to use extracorporeal membrane oxygenation (odds ratio, 9.64; 95% confidence intervals, 2.19-42.4; P < .001).
This study has shown the survival benefit of surgical intervention in high-risk patients with acute coronary syndrome or ST-segment elevation myocardial infarction who had cardiogenic shock after percutaneous coronary intervention.
本研究的目的是找出患有急性冠状动脉综合征和ST段抬高型心肌梗死并发生心源性休克患者的最佳治疗策略。
从台湾一家三级医疗中心的临床信息系统中回顾性检索因急性冠状动脉综合征和ST段抬高型心肌梗死而发生心源性休克且需要主动脉内球囊反搏进行血流动力学支持的患者。应用基于倾向评分的匹配过程来找出两组均衡的患者,一组为仅接受经皮冠状动脉介入治疗(仅PCI组)且记录显示累及2支以上冠状动脉的患者,另一组为经皮冠状动脉介入治疗后接受冠状动脉旁路移植术(PCI+CABG组)的患者。使用逻辑回归模型找出与30天死亡率相关的因素。
倾向分析确定仅PCI组有44例患者(35例男性,65±2岁,9例女性,75±4岁),PCI+CABG组有另外44例患者(31例男性,67±2岁,13例女性,71±2岁),两组具有可比的基线特征。30天死亡率方面,仅PCI组为40.9%,PCI+CABG组为20.5%,仅接受经皮冠状动脉介入治疗与之呈正相关(比值比,3.33;95%置信区间,1.14 - 10.0;P = 0.03),年龄增加与之呈正相关(每年比值比,1.06;95%置信区间,1.01 - 1.12;P = 0.01),以及需要使用体外膜肺氧合与之呈正相关(比值比,9.64;95%置信区间,2.19 - 42.4;P < 0.001)。
本研究表明,对于经皮冠状动脉介入治疗后发生心源性休克的急性冠状动脉综合征或ST段抬高型心肌梗死高危患者,手术干预具有生存获益。